RESEARCH COMMUNICATION
|
|
- Darlene Fields
- 5 years ago
- Views:
Transcription
1 Preoperative Serum CEA, CA19-9 and CA 125 as Prognostic Factors for Colorectal Cancer RESEARCH COMMUNICATION Preoperative Serum Carcinoembryonic Antigen, Carbohydrate Antigen19-9 and Carbohydrate Antigen 125 as Prognostic Factors for Recurrence-free Survival in Colorectal Cancer Xue-Qin Yang 1,2, Chuang Chen 1, Fu-Bing Wang 1, Chun-Wei Peng 1, Yan Li 1 * Abstract Objective: Colorectal cancer (CRC) is among the most common malignancies worldwide. Understanding CRC prognosis at the initial diagnosis is very important for therapeutic strategy selection. This study was conducted to evaluate the prognostic value of preoperative serum carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125) for predicting 5-year recurrence-free survival (RFS) in CRC patients. Methods: Preoperative serum CA19-9, CEA and CA125 levels were detected by C12 protein chip diagnostic system in 103 patients with CRC, and their correlations with the 5-year RFS were analyzed. Results: Patients with positive preoperative serum CA19-9, CEA and CA125 had higher 5-year recurrent rates (75.0% vs 41.0%, 65.6% vs 39.4%, and 87.5% vs 44.2% respectively, all p<0.05), and reduced median RFS (14 vs 35 months, 20 vs 36 months, and 4 vs 35 months respectively, all p<0.05) compared with patients negative for corresponding tumor marker (TM). The median RFS was 59 months (95% CI months) with negative TMs, 14 months (95% CI ) for 1~2 positive TMs, and 4 months (95% CI ) for all 3 positive TMs. Patients with simultaneously positive serum CA19-9, CEA and CA125 had the highest recurrence rate (100%) and the shortest RFS (median 4 months). Univariate analysis showed that stage and the preoperative single TM or combined TMs correlated with RFS, whereas multivariate Cox regression model analysis revealed only stage and preoperative serum status of CEA+CA19-9+CA125 to be independent prognostic factors. Conclusion: Preoperative serum CA19-9+CEA+CA125 can be used an independent prognostic factor for CRC 5-year RFS. Keywords: Colorectal cancer - CA CEA - CA recurrence-free survival - China Asian Pacific J Cancer Prev, 12, Introduction Colorectal cancer (CRC) is among the most common malignancies worldwide, with an estimated 1.2 million new cases and 0.6 million deaths each year (Jemal et al., 2011). Information form 2010 Health Statistical Yearbook of China showed that the morbidity and mortality of CRC ranked fifth in China during (Ministery of Health of the People s Republic of China, 2010). With changes in lifestyle, diet and disease spectrum, the incidence of CRC has been on the steady increase in recent years. Tumor marker (TM) is a substance that can be detected in the blood, urine, or other body fluids or tissues in patients with cancer, which could be an important tool in cancer diagnosis, prognosis, treatment decision making and disease monitoring (Zhang et al., 2009). With the development of molecular biological techniques and new discoveries in cancer biology, many serum TMs such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9(CA19-9), carbohydrate antigen 242, carbohydrate antigen 724 and tissue inhibitor of metalloproteinase type 1, etc. have been explored. The American Society of Clinical Oncology (ASCO) and European Group on Tumor Markers (EGTM) published and updated evidencebased clinical practice guidelines for the use of TMs in CRC (Locker et al., 2006; Duffy et al., 2007). The guidelines stated that lack of specificity and sensitivity precluded the use of all existing serum markers for the early detection of CRC, only CEA had some values in prognosis, surveillance and monitoring. However, there was no such standard guideline for the use of serum TMs in CRC in China, and no better TMs used in clinical work. Many traditional TMs are still used in clinical practice. Considering ethnical and geographical factors, we investigated the clinical use of the commonly used serum TMs in CRC. Our previous study on the application of C12 multi-tumor marker protein chip in 173 consecutive CRC patients, identified three relatively useful TMs, CEA, CA19-9 and carbohydrate antigen 125 (CA125) (Yang 1 Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory on Tumor Biological Behavior and Hubei Cancer Clinical Study Center, Wuhan, 2 Medical School of Jingchu University of Technology, Jingmen, China *For correspondence: liyansd2@163.com Asian Pacific Journal of Cancer Prevention, Vol 12,
2 Xue-Qin Yang et al et al., 2009). The positive rates of CEA, CA19-9 and CA125 were 36.4 %, 18.5% and 9.8%, respectively, but the positive rates in stage I CRC were only 3.9%, 5.9%, and 3.9%, respectively (Yang et al., 2009). The results suggested that the diagnostic role of the TMs was poor in CRC patients, especially in early stage CRC, which was in accordance with the standard points of ASCO and EGTM. TMs positive rate elevated with advancing stage, suggesting their role in predicting prognosis. With the wishing to add more evidence or data to objectively define the values of commonly used serum TMs CA19-9, CEA and CA125 in CRC, we conducted the present study to explore the relationship between preoperative serum CA19-9, CEA and CA125 levels and 5-year recurrencefree survival (RFS) of the CRC patients. Materials and Methods Patient selection and blood samples Patients meeting the following criteria were enrolled in this study: (1) curative resection for biopsy confirmed CRC; (2) preoperative serum samples available; and (3) complete follow-up information available. On the basis of 173 CRC cases in our previous study (Yang et al., 2009), we had further increased the sample size to 199 cases. During follow-up periods, some patients changed hospitals and some patients lost contact. Up to the last follow-up date, 103 cases had complete follow-up data for 5-year RFS analysis. Peripheral blood was obtained at the preoperative workup. And the serum was separated and stored at -20ºC until detection using the C12 protein chip system according to the protocol supplied by the manufacturer (Shanghai HealthDigit Co., Ltd. Shanghai, China). Peripheral blood samples from 138 healthy Chinese volunteers were collected as normal controls. The ages of controls ranged from years old, the median age was 51 years old. Among 138 controls, 86 were males and 52 were females. Clinical follow-up and recurrence definition Postoperative follow-ups were scheduled according to standard guidelines, covering such items as detailed history recording, physical examination, TMs tests, medical imaging studies or biopsies as deemed necessary. As the purpose of this study was to investigate the correlation between preoperative TMs and 5-year recurrence in CRC, for practical clinical utility, this study defined recurrence as clinical recurrence, medical imaging 1252 Asian Pacific Journal of Cancer Prevention, Vol 12, 2011 recurrence, and pathological recurrence. If the patient had curative comprehensive treatment developed any clinical manifestations highly indicative of cancer recurrence, but could not be confirmed by biopsy and could not be relieved by routine treatments, then the patient was diagnosed as having clinical recurrence. If medical imaging studies discovered any mass in the operation field, the whole abdominal-pelvic cavity, the liver, the lungs, and the bone marrow, during the follow-up period in a patient who had previously underwent curative treatment for CRC, then it was considered as medical imaging recurrence Pathological recurrence was defined as any biopsy confirmed diagnosis during the follow-up period. In this study, if any of the above 3 types of recurrence occurred 75.0 in a patient, the diagnosis of recurrence was established. RFS was defined as the time interval from curative surgery to the diagnosis of recurrence Statistical analysis The recurrent rates among different individual TMs status were assessed with Chi-square test. The correlations 25.0 of preoperative TMs with RFS were analyzed using the Kaplan Meier product limit method and Log rank test. Cox regression model was used to select significant predictors of recurrence. Statistical analyses were 0 performed with SPSS 13.0 (SPSS Inc. Chicago, IL). P<0.05 was considered as statistically significant. Results TM status of CRC patients In the 103 cases, the median serum levels (ranges) of CA19-9, CEA and CA125 were 10.6 ( ) ku/l, 2.4 ( ) μg/l and 8.6 ( ) ku/l, respectively. The cut-off values of CA19-9, CEA and CA125 were 35 ku/l, 5 μg/l, and 35 ku/l, respectively. The preoperative TMs status, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CA19-9, CEA and CA125 individually and collectively are summarized in Table 1. The positive rates of these TMs increased with advancing stage. Combined detection of three TMs had highest positive rate, but had no significant difference compared with any single TM (p>0.05). The combined detection of CEA+CA19-9 or CEA+CA19-9+CA125 increased the sensitivity and NPV. Preoperative TM status and CRC recurrence TM status and CRC recurrence was shown in Table 2. Among 103 CRC patients, the 5-year recurrent rates Table 1. Preoperative Serum TMs Status of 103 Patients with CRC and 138 Controls TMs Positive Positive patients with CRC by Stage Sens. Spec. PPV NPV controls (138) Ⅰ (9) Ⅱ (33) Ⅲ (44) Ⅳ (17) Total (103) p-value CA ( 6.1 ) 9 (20.5) 9 (52.9) 20 (19.4) CEA 2 (1.45) 1(11.1) 6 (18.2) 14 (31.8) 11 (64.7) 32 (24.6) CA125 1 (0.72) 0 3 ( 9.1 ) 1 ( 2.3 ) 4 (23.5) 8 ( 7.8 ) CA19-9+CEA 2 (1.45) 1(11.1) 6 (18.2) 18 (40.9) 13 (76.5) 38 (36.9) CA19-9+CA125 1 (0.72) 0 5 (15.2) 10 (22.7) 10 (58.8) 25 (23.8) CEA+CA125 2 (1.45) 1(11.1) 7 (21.2) 15 (34.7) 12 (70.6) 35 (34.0) All Three TMs 2 (1.45) 1(11.1) 7 (21.2) 19 (43.2) 14 (82.4) 41 (39.8) N, number; PPV, positive predictive value; NPV, negative predictive value; Sens., sensitivity; Spec., specificity Newly diagnosed without treatment
3 Preoperative Serum CEA, CA19-9 and CA 125 as Prognostic Factors for Colorectal Cancer Table 2. Preoperative TM Status and 5-year Recurrence longer RFS comparing with those with any positive TM TM status No. Rate (%) p-value (Log rank test, p<0.05). CA19-9 negative (41.0) CA19-9 positive (75.0) CEA negative (39.4) CEA positive (65.6) CA125 negative (44.2) CA125 positive 8 7 (87.5) CA19-9+CEA negative (33.9) CA19-9+CEA any positive (71.1) CA19-9+CA125 negative (38.5) CA19-9+CA125 any positive (76.0) CEA+CA125 negative (38.2) CEA+CA125 any positive (65.7) CA19-9+CEA+CA125 negative (30.6) CA19-9+CEA+CA125 any positive (73.2) 1~2 TMs positive (68.4) TMs simultaneously positive 3 3 (100 ) Total CRC patients (47.6) --- CI,confidence interval; SE, standard error of the patients with positive TMs were significant higher than those with negative TMs: 75.0% vs 41.0% for CA19-9 (p=0.006), 65.6% vs 39.4% for CEA (p=0.014), and 87.5% vs 44.2% for CA125 (p=0.019). When TMs combination detected, any one positive was defined as positive outcome, whereas all TMs negative was defined as negative outcome. Among 2 TMs combination detection, CA19-9+CEA showed best predictive value, the 5-year recurrent rate of patients with positive CA19-9+CEA was 71.05%, which was significantly higher than those with negative CA19-9+CEA (33.9%) (p=0.000). When 3 TMs CA19-9+CEA+CA125 combination detected, 5-year recurrent rate of patients with positive and negative TMs were 73.2% and 30.6% (p=0.000), respectively. Patients with 1 ~ 2 positive TMs had 68.4% recurrent rate in 5 years, but those with 3 positive TMs had 100% recurrent rate within 2 years. Numbers of positive TMs and RFS Among 103 CRC patients, 62 patients had normal preoperative TMs, 25 patients had 1 positive preoperative TM, 13 patients had 2 simultaneously positive TMs, 3 patients had 3 simultaneously positive TMs. Of the 13 patients with 2 simultaneously positive TMs, 11 patients had simultaneously positive CA19-9 and CEA; only 2 patients had simultaneously positive CEA and CA125. Therefore, the difference between combined detection of CEA+CA19-9 and CEA+CA19-9+CA125 was especially compared. As shown in Figure 3, patients with three simultaneously positive TMs had significantly reduced 5-year RFS. Factors correlated with 5-year RFS When exploring the factors correlated with RFS, Spearman correlation analysis indicated that stage (r=- Figure 1. The 5-year RFS of Patients with CRC in Different Stage and Preoperative Serum Status of Single TM RFS and recurrent status of 103 CRC cases As to May of 2010, the median follow-up was 25.5 months (4-60+ months). Of 103 CRC patients, 3 of 9 patients relapsed in stage Ⅰ; 6 of 33 patients relapsed in stage Ⅱ; 26 of 44 patients relapsed in stage Ⅲ; 14 of 17 patients relapsed in stage Ⅳ. Totally, 49 (47.6%) patients relapsed during follow-up periods. The RFS curves of CRC patients in different stages were shown in Figure 1. RFS decreased significantly in advanced stage than that in early stage (Log rank test, p<0.0001). Relationship of preoperative single TM with RFS The correlation of preoperative single TM with RFS was shown in figure 1. The patients with normal preoperative serum TM had significant longer RFS time comparing with those patients with elevated preoperative serum TM. Figure 2. TMs Combination Detection and 5-year RFS of Patients with CRC Relationship of preoperative combined TMs with RFS The relationships between preoperative combined detection of CA19-9+CEA, CA19-9+CA125, CEA+CA125 and CA19-9+CEA+CA125 with RFS were shown in Figure 2. The patients with negative TMs had a Figure 3. The Number of positive TM and 5-year RFS of Patients with CRC Asian Pacific Journal of Cancer Prevention, Vol 12,
4 Xue-Qin Yang et al p=0.00), preoperative serum TM status, CA19-9 (r=0.270, p=0.006), CEA (r=0.243, p=0.014), CA125 (r=0.232, p=0.018), CEA+CA19-9 (r=0.359, p=0.000), CEA+CA125 (r=0.241, p=0.014), CA19-9+CA125 (r=0.342, p=0.000), CEA+CA19-9+CA125 (r=0.377, p=0.000) had correlations with 5-year RFS of patients with CRC. Univariate analysis indicated that stage, the preoperative serum TM status of three single TM and any combination of three TMs had correlations with 5-year RFS. Multivariate analysis with Cox regression model revealed that only stage (p<0.001) and preoperative serum status of combined detection of CA19-9+CEA+CA125 (p<0.001) were independent prognostic factors for 5-year of CRC. Discussion Knowledge about the CRC prognosis could help to individualize therapy choice at the time of primary diagnosis. Currently, the disease stage is regarded as the gold standard for predicting prognosis. However, it is difficult to accurately determine the stage prior to surgical treatment. Furthermore, patients with CRC with the same disease stage display survival heterogeneity, with some patients exhibiting recurrence diversity. With advances in understanding the biological behaviors of tumor, a variety of biological factors on prognosis have attracted considerable attention. A study (Auf et al., 2010) recently investigated the expression of cytokeratin 20 (CK20) and vascular endothelial growth factor (VEGF) in the peripheral blood of Egyptian CRC patients, the result showed that both CK20 and VEGF significantly increased in advancing CRC stage C and with lymph nodes metastasis. Another study (Ferroni et al., 2010) reported that positive presurgical se-selectin levels were associated with an increased recurrence rate compared with patients with low levels of this molecule in CRC patients. Although numerous new TMs (Auf et al., 2010; Ferroni et al., 2010; Tang et al., 2009; Holten-Andersen et al., 2004; Mroczko et al., 2007; Demirci et al., 2009; Sun et al., 2009; Rosen et al., 2005 ) have been suggested for CRC, the ideal serum TM is still not available for routine clinical application. Classical TMs CA19-9, CEA, and CA125 still play major role in clinical practice. This study focused on the relationship between preoperative serum TMs status and RFS in 103 CRC patients with complete 5-year follow-up information. We found that patients with positive CEA, CA19-9 or CA125 had significantly higher recurrent rate and shorter 5-year RFS than those patients with negative TMs (p<0.05). Multivariate Cox regression model analysis confirmed that preoperative CEA+CA19-9+CA125 was an independent prognosis factors for RFS. On further analysis, it was found that patients with 3 simultaneously positive serum CA19-9, CEA and CA125 had significantly reduced RFS comparing with negative patients. Single TM detection had relatively high specificity and PPV, but very low sensitivity and NPV in our previous study (Yang et al., 2009; Yang et al., 2010) and this study (table 2). These results suggest that 1254 Asian Pacific Journal of Cancer Prevention, Vol 12, 2011 combined detection of CA19-9, CEA and CA125 could increase the predicting value for RFS. CEA is a high molecular weight glycoprotein in the immunoglobulin superfamily and has been used as an important biomarker of CRC. High CEA levels may also be found in other conditions such as hepatitis, inflammatory bowel disease, pancreatitis, and obstructive pulmonary disease (Kim et al., 2008). Its usefulness in CRC has been explored extensively (Morita et al., 2004; Duffy, 2001; Park et al., 2009). A study reported that high preoperative CEA correlated with adverse prognosis and the most useful application of CEA is in the detection of liver metastasis from CRC (Duffy, 2001). Another study found that patients with high preoperative CEA levels (>7.0 ng/ml) were significantly more likely to have perineural invasion, more aggressive tumor stage, and tumor recurrence than were patients with normal preoperative CEA (Park et al., 2009). CEA concentrations significantly rose with the clinical stage of CRC (Mroczko et al., 2007). In keeping with these results, this study showed the patients with positive preoperative CEA had shorter 5-year RFS, but it was not an independent prognosis factor for 5-year RFS in multivariate analysis. CA19-9 is most commonly used in detecting pancreatic adenocarcinoma, although it is also a TM in detecting CRC. The prognostic value of CA19-9 remains controversial. A study reported that the CA19-9 level was not a predictor of prognosis (Morita et al., 2004). But another study found a contradictory result: preoperative high CA19-9 (>37.0U/mL) was an independent prognostic factor for recurrence, and patients with high preoperative CA19-9 levels were significantly to show lymphatic invasion, perineural invasion, more advanced tumor stage and recurrence than patients with normal preoperative CA19-9 levels (Papk et al., 2009). This study confirmed that CRC patients with positive preoperative CA19-9 had significantly higher recurrent rate and shorter 5-year RFS than those with normal CA19-9. But, again, preoperative CA19-9 was not an independent prognostic factor for 5-year RFS in multivariate analysis. Serum CA125 levels can elevate in various normal and pathologic conditions that affect the endometrium, including menstruation, pregnancy, endometriosis, and endometrial cancer (Baron et al., 2005; Miralles et al., 2003).It is most commonly used in detecting ovarian cancers (Rosen et al., 2004), but it is not ovarian cancer specific and can also elevate in other cancers such as carcinoma of the breast, lung and CRC. In CRC, elevated CA125 might be correlated with serosal involvement and peritoneal spread (Miralles et al., 2003). In our previous and present study, the positive rate of CA125 was very low, especially in early stage, but in stage Ⅳ, the positive rate increased significantly. Of 8 patients with positive preoperative serum CA125, 7 patients relapsed during follow-up periods, 1 patient could not be contacted with after 8 months survival without recurrence, and the median 5-year RFS of patients with preoperative positive CA125 was only 4 months, which was the shortest among the three TMs. Considering all the factors including its sensitivity (7.8%) and NPV (59.1%), we concluded that the elevated preoperative serum CA125 was a dismal factor for RFS
5 in CRC patients. The guidelines of ASCO and EGTM recommended that CEA could be used in predicting prognosis, surveillance following curative resection and monitoring therapy in advanced disease (Duffy et al., 2007; Locker et al., 2006). The guidelines did not recommend CA19-9 as a useful TM in CRC, and even did not mention CA125 as a TM for CRC. This study confirmed the fact that the three individual TM was not an independent prognostic factor for 5-year RFS in patients with CRC. However, combination use of these TMs might be shown values in CRC. The 3 TMs combined detection was an independent prognostic factor in this study. In comparison with other studies (Sun et al., 2009; Morita et al., 2004; Papk et al., 2009), this study had both consistency and inconsistency with theirs. Some considerations might account for the confusing and even contradictory results. First, different definitions of abnormal TM levels or different methods for TM detection were used. Second, different study may have different sample size and employ different ethnic or race group. Third, different statistical methods were used and may have resulted in different conclusions. Fourth, different definition of RFS may be taken. Fifth, different patients might experience different treatment and different followup periods. A study (Dogan et al., 2010) recently reported that perioperative blood transfusion was a factor related to disease-free survival and overall survival of CRC. There are two main limitations in this study. One is the relatively small sample size; the other is too many patients losing follow-up, which may be produced some bias. However, the results in this study were very objective, and we believed that the results in this study could play some instructing role in clinical practice. In conclusion, increased preoperative CA19-9+CEA+CA125 is an independent negative prognostic factor for 5-year RFS of patients with CRC. Acknowledgements Supported by Jingmen Science and Technology Planning Project (No. 2010S21), the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education (2010), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (No and ). References Auf FA, El-Ebidy GK, Mosaad YM, et al (2010). Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer. J Oncol Pharm Pract, (Epub ahead of print). Baron AT, Boardman CH, Lafky JM, et al (2005). Soluble epidermal growth factor receptor (SEG-FR) and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev, 14, Demirci U, Coskun U, Sancak B, et al (2009). Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma? Asian Pac J Cancer Prev, 10, Preoperative Serum CEA, CA19-9 and CA 125 as Prognostic Factors for Colorectal Cancer Dogan L, Karaman N, Yilmaz KB, et al (2010). Characteristics and risk factors for colorectal cancer recurrence. J BUON, 15, Duffy MJ, van Dalen A, Haglund C, et al (2007).Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer, 43, Duffy MJ (2001). Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem, 47, Ferroni P, Roselli M, Spila A, et al (2010). Serum se-selectin levels and carcinoembryonic antigen mrna-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients. Cancer, 116, Holten-Andersen M, Christensen IJ, Nilbert M, et al (2004). Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study. Eur J Cancer, 40, Holten-Andersen MN, Fenger C, Nielsen HJ, et al (2004). Plasma TIMP-1 in patients with colorectal adenomas: a prospective study. Eur J Cancer, 40, Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, Kim HJ, Yu MH, Kim H, et al (2008). Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep, 41, Locker GY, Hamilton S, Harris J, et al (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, Ministery of Health of the People s Republic of China (2010). Mortality rate of 10 main malignant neoplasms from 2004 to Available from: business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html. Accessed March, 22, Miralles C, Orea M, España P, et al (2003). Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol, 10, Morita S, Nomura T, Fukushima Y, et al (2004). Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum, 47, Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, et al (2007). Serum macrophagecolony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta, 380, Papk IJ, Choi GS,Jun SH (2009). Prognostic value of serum tumor antigen ca19-9 after curative resection of colorectal cancer. Anticancer Res, 29, Park IJ, Choi GS, Lim KH, et al (2009). Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol, 16, Rosen DG, Wang L, Atkinson JN, et al (2005). Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol, 99, Sun LC, Chu KS, Cheng SC, et al (2009). Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer, 9, Tang R, Yeh CY, Wang JY, et al (2009). Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. Ann Surg Oncol, 16, Yang XQ, Yan L, Chen C, et al (2009). Application of C12 multitumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement. Hepato-gastroenterology, 56, Yang XQ, Li Y, Chen C, et al (2010). Preoperative serum carbohydrate antigen 125 level is an independent negative Asian Pacific Journal of Cancer Prevention, Vol 12,
6 Xue-Qin Yang et al prognostic marker for overall survival in colorectal cancer. Med Oncol, (Epub ahead of print). Zhang YH, Li Y, Chen C, et al (2009). Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy. Hepato-gastroenterology, 56, Asian Pacific Journal of Cancer Prevention, Vol 12, 2011
Original Article. Chen C, Chen LQ 1, Yang GL, Li Y
Original Article www.jpgmonline.com The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: Systematic evaluation and suggestion for improvement Chen C, Chen LQ 1, Yang GL,
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationCancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006
Chinese Journal of Cancer Original Article Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006 Xiao-Pan Li 1, Guang-Wen Cao 2, Qiao
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationRESEARCH COMMUNICATION. High Ki-67 Expression is a Poor Prognostic Indicator of 5-Year Survival in Patients with Invasive Breast Cancer
RESEARCH COMMUNICATION High Ki-67 Expression is a Poor Prognostic Indicator of 5-Year Survival in Patients with Invasive Breast Cancer Xue-Qin Yang 1,2, Fu-Bing Wang 1, Chuang Chen 1, Chun-Wei Peng 1,
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationReview Article Evaluation of serum CEA for the gastrointestinal cancer diagnosis using different cut-off values
Int J Clin Exp Pathol 2016;9(8):7807-7812 www.ijcep.com /ISSN:1936-2625/IJCEP0032436 Review Article Evaluation of serum CEA for the gastrointestinal cancer diagnosis using different cut-off values Dong-Ze
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationRESEARCH ARTICLE. Bo He 1, Hui-Qing Zhang 1 *, Shu-Ping Xiong 2, Shan Lu 1, Yi-Ye Wan 1, Rong-Feng Song 1. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.8.3111 Changes of CEA and CA199 Levels in Advanced Gastric Adenocarcinoma RESEARCH ARTICLE Changing patterns of Serum CEA and CA199 for Evaluating the Response
More informationRESEARCH ARTICLE. Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamount to being Cured?
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.2.661 Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamount to being Cured? RESEARCH ARTICLE Normalization of CA19-9
More informationCombined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer
He et al. BMC Gastroenterology 2013, 13:87 RESEARCH ARTICLE Open Access Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer Chao-Zhu He 1,2, Kun-He Zhang
More informationDIAGNOSTIC SIGNIFICANCE OF CHANGES IN SERUM HUMAN EPIDIDYMIS EPITHELIAL SECRETORY PROTEIN 4 AND CARBOHYDRATE ANTIGEN 125 IN ENDOMETRIAL CARCINOMA
Acta Medica Mediterranea, 2018, 34: 785 DIAGNOSTIC SIGNIFICANCE OF CHANGES IN SERUM HUMAN EPIDIDYMIS EPITHELIAL SECRETORY PROTEIN 4 AND CARBOHYDRATE ANTIGEN 125 IN ENDOMETRIAL CARCINOMA PATIENTS JING-LI
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationTHE RELEVANCE OF SOME TUMORAL MARKERS IN PATIENTS WITH PANCREATIC CANCER
THE RELEVANCE OF SOME TUMORAL MARKERS IN PATIENTS WITH PANCREATIC CANCER DANIEL TIMOFTE 1, RADU DANILA 1*, ALIN CIOBICA 2, CORNELIU DIACONU 1, ROXANA LIVADARIU 3, LIDIA IONESCU 1 Keywords: pancreatic cancer,
More informationRESEARCH ARTICLE. Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.1.159 RESEARCH ARTICLE Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran Mohammad Zare-Bandamiri 1, Narges Khanjani 2 *, Yunes Jahani
More informationAnalysis of the prognosis of patients with testicular seminoma
ONCOLOGY LETTERS 11: 1361-1366, 2016 Analysis of the prognosis of patients with testicular seminoma WEI DONG 1, WANG GANG 1, MIAOMIAO LIU 2 and HONGZHEN ZHANG 2 1 Department of Urology; 2 Department of
More informationImpact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery
Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationDiagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer
IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Diagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer To cite this article: J Sembiring et al 2018
More informationRESEARCH ARTICLE. Masaki Tomita 1, Takanori Ayabe 1, Eiichi Chosa 1, Naohiro Nose 1, Kunihide Nakamura 2 * Abstract. Introduction
RESEARCH ARTICLE Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer Masaki Tomita 1, Takanori
More informationCarcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
More informationSurgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14
Surgical Management of Advanced Stage Colon Cancer Nathan Huber, MD 6/11/14 Colon Cancer Overview Approximately 50,000 attributable deaths per year Colorectal cancer is the 3 rd most common cause of cancer-related
More informationCitation for published version (APA): Bartels, S. A. L. (2013). Laparoscopic colorectal surgery: beyond the short-term effects
UvA-DARE (Digital Academic Repository) Laparoscopic colorectal surgery: beyond the short-term effects Bartels, S.A.L. Link to publication Citation for published version (APA): Bartels, S. A. L. (2013).
More informationThe clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer
J Korean Surg Soc 2013;84:231-237 http://dx.doi.org/10.4174/jkss.2013.84.4.231 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 The clinical significance of
More informationDr. Shari Srinivasan, Consultant Chemical Pathologist, Tallaght Hospital, Dublin 24, Ireland
Draft Laboratory Testing for Tumour Markers V1.0 Authors Dr. Shari Srinivasan, Consultant Chemical Pathologist, Tallaght Hospital, Dublin 24, Ireland Dr. Gerard Boran, Consultant Chemical Pathologist,
More informationTitle: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen
Author's response to reviews Title: Synuclein Gamma Predicts Poor Clinical Outcome in Colon Cancer with Normal Levels of Carcinoembryonic Antigen Authors: Caiyun Liu (liucaiyun23@yahoo.com.cn) Bin Dong
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationThe diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 4039-4044 The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer H.-Y. FAN
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationSMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske
SMALL BOWEL ADENOCARCINOMA Dr. C. Jeske Case presentation 54 year old female. Presents with OJ and weight loss. Abdominal examination only reveals a palpable gallbladder. ERCP reveals a circumferential
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationPatient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201
Patient Presentation 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 CT shows: Thickening of the right hemidiaphragm CT shows: Fluid in the right paracolic sulcus CT shows: Large
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationExosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study
GBCC 2017: ABS-0017 Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study Soo Jung Lee 1, Jeeyeon Lee 2, Jin Hyang Jung 2, Ho Yong Park 2, Chan Hyeong Lee 3, Pyong
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationPrognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China
1663 Ivyspring International Publisher Research Paper Journal of Cancer 2016; 7(12): 1663-1667. doi: 10.7150/jca.15216 Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous
More informationGlasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma
Int Surg 2014;99:512 517 DOI: 10.9738/INTSURG-D-13-00118.1 Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma Tadahiro Nozoe, Rumi Matono,
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationTUMOR M ARKERS MARKERS
TUMOR MARKERS M.Shekarabi IUMS Definition Many cancers are associated with the abnormal production of some molecules l which h can be measured in plasma. These molecules are known as tumor markers. A good
More informationCorrelation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer
Correlation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer J.H. Sun 1, N. Fan 2 and Y. Zhang 1 1 Xianyang Hospital of Yan an University Clinical Laboratory,
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationTaiwan. Taiwan. 807, Taiwan. Taiwan
Annals of Surgical Oncology 15(8):2120 2128 DOI: 10.1245/s10434-008-9961-7 Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I III Colorectal
More informationRESEARCH COMMUNICATION
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.1.199 RESEARCH COMMUNICATION Prognostic Significance of CYFRA21-1, CEA and Hemoglobin in Patients with Esophageal Squamous Cancer Undergoing Concurrent Chemoradiotherapy
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationDiagnostic and prognostic value of CEA, CA19 9, AFP and CA125 for early gastric cancer
Feng et al. BMC Cancer (2017) 17:737 DOI 10.1186/s12885-017-3738-y RESEARCH ARTICLE Open Access Diagnostic and prognostic value of CEA, CA19 9, AFP and CA125 for early gastric cancer Fan Feng 1, Yangzi
More informationCircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 3713-3718 CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer N. LIU 1, J. ZHANG 1, L.-Y. ZHANG 1, L.
More informationSatisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy
Original Article Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Shupeng Zhang 1, Liangliang Wu 2, Xiaona Wang 2, Xuewei Ding 2, Han Liang 2 1 Department of General
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationRESEARCH ARTICLE. Qian Liu, Jian-Jun Bi, Yan-Tao Tian, Qiang Feng, Zhao-Xu Zheng, Zheng Wang* Abstract. Introduction. Materials and Methods
RESEARCH ARTICLE Outcome after Simultaneous Resection of Gastric Primary Tumour and Synchronous Liver Metastases: Survival Analysis of a Single-center Experience in China Qian Liu, Jian-Jun Bi, Yan-Tao
More informationIncreased Mortality Associated with Elevated Carcinoembryonic Antigen in Insurance Applicants
Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:251 258 MORTALITY Increased Mortality Associated with Elevated Carcinoembryonic Antigen in Insurance Applicants Robert L. Stout, PhD;
More informationExpression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 3397-3401 Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival W.-X. LI 1, R.-L.
More informationExpression of lncrna TCONS_ in hepatocellular carcinoma and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 5655-5660 Expression of lncrna TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival Q. CHEN 1, G.-D.
More informationGUOPEI LUO, PhD, MD. Shanghai Cancer Center, Shanghai, China. Joint-trained Ph.D. student, from 2008 to 2009, University of California, Irvine
GUOPEI LUO, PhD, MD EDUCATION Shanghai Cancer Center, Shanghai, China Joint-trained Ph.D. student, from 2008 to 2009, University of California, Irvine Ph.D. student specialized in pancreatic cancer, from
More informationCLINICAL SCIENCE. doi: /S
CLINICS 2009;64(4):287-94 CLINICAL SCIENCE Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients- is it important? Ali Ilker Filiz, Ilker Sucullu, Yavuz Kurt, Dursun Ozgur
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationTitle: What is the role of pre-operative PET/PET-CT in the management of patients with
Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June
More informationFactors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage
Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage Jessica Johns, MD Jeffrey Killeen, MD Robert Kim, MD Hyeong Jun Ahn, PhD None Disclosures
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationTreatment strategy of metastatic rectal cancer
35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent
More informationPrognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
Hou et al. World Journal of Surgical Oncology (2018) 16:198 https://doi.org/10.1186/s12957-018-1504-5 REVIEW Open Access Prognostic significance of metastatic lymph node ratio: the lymph node ratio could
More informationRadical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients
Original Article : oncologic outcome in 271 Chinese patients Zhi-Ling Zhang, Pei Dong, Yong-Hong Li, Zhuo-Wei Liu, Kai Yao, Hui Han, Zi-Ke Qin and Fang-Jian Zhou Abstract Few large scale studies have reported
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationSequential screening in the early diagnosis of colorectal cancer in the community
Journal of Public Health: From Theory to Practice https://doi.org/10.1007/s10389-019-01024-0 ORIGINAL ARTICLE Sequential screening in the early diagnosis of colorectal cancer in the community Ming-sheng
More informationThe diagnostic, prediction of postoperative recurrence and prognostic value of HE4 in epithelial ovarian cancer
JBUON 2018; 23(2): 428-432 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE The diagnostic, prediction of postoperative recurrence and prognostic
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationTumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.
Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer
More informationPrognostic significance of nemo like kinase in nasopharyngeal carcinoma
MOLECULAR MEDICINE REPORTS 10: 131-136, 2014 Prognostic significance of nemo like kinase in nasopharyngeal carcinoma SIZE CHEN 1,2*, ZHIJIAN MA 3*, XUEMEI CHEN 4 and JIREN ZHANG 1 1 Department of Oncology,
More informationEvaluation of serum level of CA-125 and HE4 in patients with an adnexal mass for the discrimination of benign from malignant cases
Evaluation of serum level of CA-125 and HE4 in patients with an adnexal mass for the discrimination of benign from malignant cases Ahmet Göçmen, Fatih Şanlıkan, Yüksel Sayın, Fatma Seda Öztürk, Abdülhamid
More informationPrognostic value of thrombocytosis and the neutrophil/lymphocyte ratio in patients with gastric cancer: A retrospective study.
Research Article http://www.alliedacademies.org/gastroenterology-and-digestive-diseases/ Prognostic value of thrombocytosis and the neutrophil/lymphocyte ratio in patients with gastric cancer: A retrospective
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationRare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital
E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.
More informationFactors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience
RESEARCH ARTICLE Editorial Process: Submission:00/00/0000 Acceptance:00/00/0000 : A 15-Year Single Center Experience Abdullah Sakin 1 *, Makbule Tambas 2, Saban Secmeler 3, Orçun Can 3, Serdar Arici 3,
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationSmoking and Histological Factors Influencing Long-term Survival of Gastric Carcinoma in Consecutive Patient Series
Original Article Middle East Journal of Cancer 2014; 5(3): 127-133 Smoking and Histological Factors Influencing Long-term Survival of Gastric Carcinoma in Consecutive Patient Series Ali Delpisheh *, Yousef
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationPhysician Follow-Up and Guideline Adherence in Post- Treatment Surveillance of Colorectal Cancer
Physician Follow-Up and Guideline Adherence in Post- Treatment Surveillance of Colorectal Cancer Gabriela M. Vargas, MD Kristin M. Sheffield, PhD, Abhishek Parmar, MD, Yimei Han, MS, Kimberly M. Brown,
More informationPreoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer
university of copenhagen Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer Birgisson, Helgi ; Nielsen, Hans J.; Christensen, Ib Jarle; Glimelius,
More informationMismatch repair status, inflammation and outcome in patients with primary operable colorectal cancer
Mismatch repair status, inflammation and outcome in patients with primary operable colorectal cancer Park JH, Powell AG, Roxburgh CSD, Richards CH, Horgan PG, McMillan DC, Edwards J James Park Clinical
More informationRESEARCH ARTICLE. Hariyono Winarto*, Bismarck Joel Laihad, Laila Nuranna. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.5.1949 RESEARCH ARTICLE Modification of Cutoff Values for HE4, CA125, the Risk of Malignancy Index, and the Risk of Malignancy Algorithm for Ovarian Cancer Detection
More informationImpact of conversion during laparoscopic gastrectomy on outcomes of patients with gastric cancer
JBUON 2017; 22(4): 926-931 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Impact of conversion during laparoscopic gastrectomy on outcomes of
More informationBR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125
BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125 Paul E. C. Sibley, Ph.D. EURO/DPC Limited BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More informationClinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
/, Vol. 7, No. 31 Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer Yao Liang 1,*, Wei Wang 1,*, Cheng Fang 1,*, Seeruttun Sharvesh Raj 1, Wan-Ming
More informationRisk Factors Predicting Colorectal Cancer Recurrence Following Initial Treatment: A 5-year Cohort Study
DOI:10.22034/APJCP.2017.18.9.2465 RESEARCH ARTICLE Following Initial Treatment: A 5-year Cohort Study Mohammad Zare-Bandamiri 1, Mohammad Fararouei 2, Shadi Zohourinia 3, Nima Daneshi 1, Mostafa Dianatinasab
More informationAppendix cancer mimicking ovarian cancer
Int J Gynecol Cancer 2002, 12, 768 772 CORRESPONDENCE AND BRIEF REPORTS Appendix cancer mimicking ovarian cancer P. A. GEHRIG *, J. F. BOGGESS*, D. W. OLLILA, P. A. GROBEN & L. VAN LE* *Division of Gynecologic
More informationAdvances in gastric cancer: How to approach localised disease?
Advances in gastric cancer: How to approach localised disease? Andrés Cervantes Professor of Medicine Classical approach to localised gastric cancer Surgical resection Pathology assessment and estimation
More informationThe impact of lymph node examination on survival of stage II colorectal cancer patients: Are 12 nodes adequate?
Formosan Journal of Surgery (2011) 44, 176e180 Available online at www.sciencedirect.com journal homepage: www.e-fjs.com ORIGINAL ARTICLE The impact of lymph node examination on survival of stage II colorectal
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More informationCOLON CANCER FOLLOW UP GUIDELINES
COLON CANCER FOLLOW UP GUIDELINES CAGPO Dr. Raziya Mia October 1, 2016 1 DISCLOSURES NONE 2 MITIGATING POTENTIAL BIAS Recommendations are consistent with published guidelines American Society of Clinical
More informationBiomedical Research 2017; 28 (21): ISSN X
Biomedical Research 2017; 28 (21): 9497-9501 ISSN 0970-938X www.biomedres.info Analysis of relevant risk factor and recurrence prediction model construction of thyroid cancer after surgery. Shuai Lin 1#,
More information